Search
for
Sort by
Research 61–90 of 1000+
- Randomized Placebo-Controlled Clinical Trial of Dutasteride for Reducing Heavy Drinking in Men
- Topical minoxidil therapy for androgenetic alopecia. A 30-month study
- Elemental content of anagen hairs in a normal Caucasian population studies with proton induced X-ray emission (PIXE).
- Vitamins and Hair: Sham or Science?
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Pathogenesis of paradoxical alopecia areata during dupilumab therapy: What is known and unknown
- Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Platelet-Rich Plasma Growth Factor Concentrated Spray (Keratogrow®) as a Potential Treatment for Androgenic Alopecia.
- BaldGraphFormer: An Explainable Deep Learning Framework for Early Baldness Prediction by Integrating Swin Transformer, Graph Attention Networks and Clinical Features
- A DESCRIPTIVE STUDY TO ASSESS THE KNOWLEDGE REGARDING STRESS-RELATED HAIR FALL AMONG NURSING STUDENTS IN SELECTED NURSING COLLEGES, MANGALURU
- Efficacy and predictive markers of response to tofacitinib and baricitinib therapy in alopecia areata: A 52-week comparative cohort study
- Table 1_Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study.docx
- Evaluation of serum vitamin D3 before and after intralesional injection of vitamin D3 in patients with alopecia areata
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- The Requirement to Monitor Low-dose Oral Minoxidil in the Management of Hair Loss
- Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials
- Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials
- “Downy hair sign”—A clue to autoimmune disease in curly hair
- Efficacy of Intralesional Vitamin D in the Treatment of Alopecia Areata Using Dermoscopy before and after Treatment
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Evaluation of Hair Density and Hair Diameter in the Adult Egyptian Population using Quantitative Trichoscopic Analysis
- Moderne Untersuchungsmethoden zur Evaluation von Haarausfall und Alopezie bei Frauen
- CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT?
- Phototrichogram 을 이용한 한국인 두피 모발 특성의 정량적 분석
- Big Self-Supervised Models Advance Medical Image Classification
- Before-after study with 24-hour ambulatory blood pressure monitoring after the first dose of 5 mg oral minoxidil
- PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY